New Prostate Cancer Treatment Delays Hormones 25 Months

Men living with metastatic prostate cancer just got a gift that matters more than extra time: extra quality time.

An international study led by Radboudumc in Nijmegen has shown that an experimental radiation treatment can postpone hormone therapy by at least 25 months in men whose prostate cancer has spread. For patients who often live another 10 to 15 years after diagnosis, those months mean the difference between feeling like themselves and battling the exhausting side effects of traditional treatment.

The innovation works like a guided missile for cancer cells. Doctors inject a molecule carrying a radioactive particle into the bloodstream, where it seeks out prostate cancer cells specifically and destroys them without damaging surrounding healthy tissue.

"It's a molecule with a radioactive particle attached which finds the cancer cell," explained James Nagarajah, a nuclear medicine expert at Radboudumc. The treatment shows no marked or long-term side effects, a stark contrast to what comes next in traditional care.

Hormone therapy, the standard treatment for metastatic prostate cancer, works but comes at a steep cost. Patients commonly experience brittle bones, chronic tiredness, and heart problems that can make daily life a struggle.

In the study, men who received the new treatment remained stable for at least 25 months before needing hormones. Even more remarkable, a quarter of patients had scans showing no visible tumors after treatment. Meanwhile, men in the control group saw their cancer worsen after just five months.

The Bright Side

This breakthrough represents more than延ed survival. It offers something patients value just as much: months or years of feeling well enough to work, travel, play with grandchildren, and live without the cloud of debilitating side effects.

For the tens of thousands of men diagnosed with metastatic prostate cancer each year, quality of life often matters more than quantity. This treatment promises both.

The therapy won't be widely available for a few years. Researchers need to study larger patient groups, and health insurance companies must negotiate coverage. But the results so far give doctors and patients a concrete reason for hope.

Every month without hormone therapy is a month men get to feel like themselves.